BUY Sun Pharmaceutical Industries Ltd. — Motilal Oswal
byMotilal OswalHorizon: NA (inferred 1 year)1 Aug 2024via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
5 other SEBI-registered advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days
Advisor consensus · same horizon·1 Aug · today
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Sun Pharmaceutical Industries
- BUY — Sumeet Bagadia, Choice Broking23 Oct 2026 · Same day · target ₹1,790 · Expired
- BUY — HSBC Securities7 Oct 2026 · ~1 year · target ₹2,100 · Active
- SELL — Rajesh Palviya, Axis Securities5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY — Sumeet Bagadia, Choice Broking29 Sept 2026 · Same day · target ₹1,875 · Expired
- BUY — 360 One Capital29 Sept 2026 · ~1 year · target ₹2,250 · Active
More from Motilal Oswal
- BUY Colgate Palmolive (India)22 Oct 2026 · ~1 year · target ₹2,000 · Active
- BUY Sapphire Foods India22 Oct 2026 · ~1 year · target ₹245 · Active
- BUY CIE Automotive India22 Oct 2026 · ~1 year · target ₹440 · Active
- BUY CREDITACCESS GRAMEEN22 Oct 2026 · ~1 year · target ₹1,450 · Active
- BUY KEI Industries22 Oct 2026 · ~1 year · target ₹5,180 · Active

